Article
Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy.
JCO precision oncology - 1 Jan 2022
Remenár Éva, Dóczi Róbert, Dirner Anna, Sipos Anna, Perjési Anita, Tihanyi Dóra, Vodicska Barbara, Lakatos Dóra, Horváth Katalin, Kajáry Kornélia, Schwáb Richárd, Déri Júlia, Lengyel Csongor György, Várkondi Edit, Vályi-Nagy István, Peták István
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.